Year: 2020
Type: article
Abstract: In this issue of Blood, Vinanica et al explore a novel strategy to enhance the efficacy of adoptive T-cell therapy through the expression of an erythropoietin (Epo) receptor capable of delivering a signal that boosts the survival and function of chimeric antigen receptor (CAR) T cells. 1
Source: Blood
Authors: M. Eric Kohler, Terry J. Fry
Institutions: Children's Hospital Colorado, University of Colorado Anschutz
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3007209397